APR 11, 2016 3:30 PM PDT

Enzyme may make HIV meds safer for heart

Antiviral medications used to control HIV and prevent its progression to AIDS improve the health and increase survival for people with HIV—but their use has been linked to the development of cardiovascular disease.

Now, researchers have identified an enzyme that may reduce the risk.
 
"The use of antivirals in HIV patients is very important to control the virus, suppress symptoms, and improve quality of life," says William Durante. "However ... they are known to increase the risk of cardiovascular disease."

“The use of antivirals in HIV patients is very important to control the virus, suppress symptoms, and improve quality of life,” says William Durante, professor of medical pharmacology and physiology at the University of Missouri School of Medicine and author of a new study published in Free Radical Biology and Medicine.

“However, antivirals also are linked to the development of metabolic disorders such as diabetes and obesity, and they are known to increase the risk of cardiovascular disease. Our study focused on protease inhibitors, a very common antiviral used to treat HIV.”

Protease inhibitors disrupt HIV’s ability to replicate and infect cells. However, they also cause endothelial cell malfunction, which can lead to cardiovascular disease.

“Endothelial cells make up the inner lining of blood vessels and are essential to vascular health,” Durante says. “When protease inhibitors are used to treat HIV, endothelial cell function is compromised. The cells’ natural tendency to promote blood flow through the vessel is lost and they also become inflamed. These issues lead to plaque build-up within arteries and, ultimately, cardiovascular disease.”

Durante knew from previous studies that the enzyme heme oxygenase-1, or HO-1, offers protection against endothelial dysfunction. Using a cell-based model of cultured human endothelial cells, his team was able to increase the amount of the enzyme within the cells.

“Increasing the presence of HO-1 in our model before exposing it to a protease inhibitor allowed the medication to do its job without causing endothelial dysfunction,” Durante says. “HO-1 shows great promise as a defender of endothelial cells in patients being treated for HIV.”

More research is needed to verify that the enzyme will prevent endothelial cell dysfunction with all antiviral medications. However, Durante feels that identifying the enzyme’s role in reducing vascular inflammation with protease inhibitors may one day make it a new option for preventing cardiovascular disease caused by HIV medications.

The National Heart, Lung and Blood Institute of the National Institutes of Health funded the work.

Source: University of Missouri

This article was originally published on futurity.org.
About the Author
  • Futurity features the latest discoveries by scientists at top research universities in the US, UK, Canada, Europe, Asia, and Australia. The nonprofit site, which launched in 2009, is supported solely by its university partners (listed below) in an effort to share research news directly with the public.
You May Also Like
JAN 08, 2020
Cardiology
JAN 08, 2020
Insecticides Linked to Increased Risk of Cardiovascular Disease and Death
New research from the University of Iowa has shown that prolonged exposure to common household insecticides may increase ...
JAN 17, 2020
Cardiology
JAN 17, 2020
Toxic Metals and Cardiovascular Risk
A meta-analysis was recently published in the British Medical Journal to try and understand if there was a link between ...
FEB 25, 2020
Drug Discovery & Development
FEB 25, 2020
FDA Approves Non-Statin Drug to Lower Cholesterol
The US Food and Drug Administration (FDA) has approved a new drug that lowers cholesterol levels.The drug, known as Nexl ...
FEB 28, 2020
Cardiology
FEB 28, 2020
Diabetes and Heart Problems Linked to Worse Prognosis of COVID-19
According to most recent data on the COVID-19, the novel coronavirus that emerged in Wuhan, China, those suffering from ...
MAR 05, 2020
Cardiology
MAR 05, 2020
Fish Oil Supplements Lower Risk of Heart Disease
Around the world, fish oil is a popular dietary supplement. Now, researchers have found that regularly consuming it may ...
MAY 15, 2020
Technology
MAY 15, 2020
What is HARVEY?
One of the biggest challenges facing clinical workers is trying to explore user interface treatment options easily witho ...
Loading Comments...